title: A stepwise increased dose of auranofin does not influence gastrointestinal side-effects.
authors.forename: F
authors.initials: F
authors.lastname: Johannsen
authors.forename: U
authors.initials: U
authors.lastname: Brodin
authors.forename: H
authors.initials: H
authors.lastname: Emmertsen
authors.forename: T M
authors.initials: TM
authors.lastname: Hansen
authors.forename: K L
authors.initials: KL
authors.lastname: Faarvang
authors.forename: P
authors.initials: P
authors.lastname: Bugge
authors.forename: G L
authors.initials: GL
authors.lastname: Nielsen
authors.forename: O H
authors.initials: OH
authors.lastname: Jensen
authors.forename: J
authors.initials: J
authors.lastname: Beyer
authors.forename: B
authors.initials: B
authors.lastname: Danneskiold-Samsøe
authors.forename: D
authors.initials: D
authors.lastname: Jarner
authors.forename: E
authors.initials: E
authors.lastname: Arfeldt
authors.forename: L
authors.initials: L
authors.lastname: Krohn
authors.forename: H
authors.initials: H
authors.lastname: Nielsen
authors.forename: S E
authors.initials: SE
authors.lastname: Nielsen
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001310:Auranofin / Q000008:administration & dosage* / Q000009:adverse effects; D003967:Diarrhea / Q000139:chemically induced; D004311:Double-Blind Method; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D012720:Severity of Illness Index
chemical_list: D018501:Antirheumatic Agents; D001310:Auranofin